HealthCare Global Enterprises Limited (NSE:HCG)

Market Cap	78.91B
Revenue (ttm)	22.23B
Net Income (ttm)	444.10M
Shares Out	139.35M
EPS (ttm)	3.14
PE Ratio	180.35
Forward PE	103.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	666,784
Average Volume	239,405
Open	547.40
Previous Close	547.40
Day's Range	544.25 - 575.00
52-Week Range	344.95 - 639.00
Beta	-0.14
RSI	58.80
Earnings Date	Aug 7, 2025

About NSE:HCG

HealthCare Global Enterprises Limited, together with its subsidiaries, provides medical and healthcare services focusing on cancer and fertility in India and internationally. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand that provides inpatient and o...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1989
• Employees: 6,150
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: HCG

Financial Performance

In 2024, NSE:HCG's revenue was 22.23 billion, an increase of 16.25% compared to the previous year's 19.12 billion. Earnings were 444.10 million, a decrease of -7.78%.